Support info of Treatment outcome and prognosis of patients with stage I-II nasal-type natural killer/T-cell lymphoma receiving induction chemotherapy with GELOX regimen and radical radiotherapy

中华放射肿瘤学杂志


	2016, Vol. 25(2): 140-145 DOI: 10.3760/cma.j.issn.1004-4221.2016.02.012

	Treatment outcome and prognosis of patients with stage I-II nasal-type natural killer/T-cell lymphoma receiving induction chemotherapy with GELOX regimen and radical radiotherapy
	Li Yiyang,Niu Shaoqing,Wen Ge,Wang Qiaoxuan,Wang Hanyu,Feng Lingling,Xia Yunfei,Zhang Yujing
	Department of Radiation Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Guangzhou 510060,China (Li YY,Wang QX,Wang HY,Feng LL,Xia YF,Zhang YJ);Department of Radiation Oncology,First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China (Niu SHQ);Department of Radiation Oncology,Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510150,China (Wen G)Zhang Yujing,Email:zhangyj@sysucc.org.cn
	Received 2015-01-08 Revised null
	Supporting info


	null